Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NMD-001 in hemodialysis patients with refractory chronic limb-threatening ischemia and foot ulcers
jRCT2033260410Recruiting
- Start
- Oct 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of NMD-001 in chronic limb-threatening ischemia (CLTI) (2 arms), sponsored by none. Started Oct 2026; status: recruiting.
02
Drugs
NMD-001
03
Conditions
chronic limb-threatening ischemia (CLTI)
Beyond the preview
Go deeper on jRCT2033260410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2033260410.